Skip to main content

Non-Hodgkin's lymphomas, version 4.2014.

Publication ,  Journal Article
Zelenetz, AD; Gordon, LI; Wierda, WG; Abramson, JS; Advani, RH; Andreadis, CB; Bartlett, N; Byrd, JC; Czuczman, MS; Fayad, LE; Fisher, RI ...
Published in: J Natl Compr Canc Netw
September 2014

Non-Hodgkin's lymphomas (NHL) are a heterogeneous group of lymphoproliferative disorders originating in B lymphocytes, T lymphocytes, or natural killer cells. Mantle cell lymphoma (MCL) accounts for approximately 6% of all newly diagnosed NHL cases. Radiation therapy with or without systemic therapy is a reasonable approach for the few patients who present with early-stage disease. Rituximab-based chemoimmunotherapy followed by high-dose therapy and autologous stem cell rescue (HDT/ASCR) is recommended for patients presenting with advanced-stage disease. Induction therapy followed by rituximab maintenance may provide extended disease control for those who are not candidates for HDT/ASCR. Ibrutinib, a Bruton tyrosine kinase inhibitor, was recently approved for the treatment of relapsed or refractory disease. This manuscript discusses the recommendations outlined in the NCCN Guidelines for NHL regarding the diagnosis and management of patients with MCL.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

September 2014

Volume

12

Issue

9

Start / End Page

1282 / 1303

Location

United States

Related Subject Headings

  • Recurrence
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Lymphoma, Non-Hodgkin
  • Humans
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zelenetz, A. D., Gordon, L. I., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., … National comprehensive cancer network, . (2014). Non-Hodgkin's lymphomas, version 4.2014. J Natl Compr Canc Netw, 12(9), 1282–1303. https://doi.org/10.6004/jnccn.2014.0125
Zelenetz, Andrew D., Leo I. Gordon, William G. Wierda, Jeremy S. Abramson, Ranjana H. Advani, C Babis Andreadis, Nancy Bartlett, et al. “Non-Hodgkin's lymphomas, version 4.2014.J Natl Compr Canc Netw 12, no. 9 (September 2014): 1282–1303. https://doi.org/10.6004/jnccn.2014.0125.
Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis CB, et al. Non-Hodgkin's lymphomas, version 4.2014. J Natl Compr Canc Netw. 2014 Sep;12(9):1282–303.
Zelenetz, Andrew D., et al. “Non-Hodgkin's lymphomas, version 4.2014.J Natl Compr Canc Netw, vol. 12, no. 9, Sept. 2014, pp. 1282–303. Pubmed, doi:10.6004/jnccn.2014.0125.
Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Byrd JC, Czuczman MS, Fayad LE, Fisher RI, Glenn MJ, Harris NL, Hoppe RT, Horwitz SM, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Nademanee A, Porcu P, Press O, Rabinovitch R, Reddy N, Reid E, Saad AA, Sokol L, Swinnen LJ, Tsien C, Vose JM, Yahalom J, Zafar N, Dwyer M, Sundar H, National comprehensive cancer network. Non-Hodgkin's lymphomas, version 4.2014. J Natl Compr Canc Netw. 2014 Sep;12(9):1282–1303.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

September 2014

Volume

12

Issue

9

Start / End Page

1282 / 1303

Location

United States

Related Subject Headings

  • Recurrence
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Lymphoma, Non-Hodgkin
  • Humans
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis